TABLE 3.

Probabilistic Decision Model Evaluating Outcomes Projected to Medicaid Sample Across 3 Treatment Strategies Over 18 Months

Outcomes	OA	PP1M→PP1M	PP1M→PP3M	OA (PP1M→PP1M) Mean (SE), P Value (95% CI)	OA (PP1M→PP3M) Mean (SE), P Value (95% CI)	(PP1M→PP1M) (PP1M→PP3M) Mean (SE), P Value (95% CI)
Hospitalizations
Psych, mean (SE)	0.50 (0.28)	0.23 (0.05)	0.19 (0.05)	0.27 (0.35), 0.440 (-0.43-0.97)	0.31 (0.28), 0.268 (-0.43-0.97)	0.04 (0.07), 0.568 (-0.10-0.18)
AC, mean (SE)	0.59 (0.28)	0.31 (0.05)	0.28 (0.05)	0.28 (0.28), 0.317 (-0.28-0.84)	0.31 (0.28), 0.268 (-0.27-0.87)	0.03 (0.07), 0.668 (-0.11-0.17)
Median time to discontinuation, days	153 (17)a	206 (24)	265 (29)	–	–	-59 (38), 0.121 (-15-133)

^a> 15 months and so is not directly comparable to other estimates.

AC = all-cause; CI = confidence interval; OA = oral antipsychotic; Psych = psychiatric; PP1M = once-monthly long-acting injectable paliperidone palmitate; PP3M = onceevery-3-months long-acting injectable paliperidone palmitate; SE = standard error.